Buserelin For Peak Identification

Get a Price/Quote

MOQ : 1 Kilograms

Buserelin For Peak Identification Specification

Usage
Buserelin is approved for the treatment of hormone-responsive cancers including prostate cancer and premenopausal breast cancer, sex hormone-dependent uterine diseases including endometrial hyperplasia, endometriosis, and uterine fibroids, and in assisted reproduction for female infertility.

Application
Industrial

Molecular Weight
1239.4 Grams (g)

Purity
98%

Molecular Formula
C60H86N16O13

Buserelin For Peak Identification Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Kilograms Per Month

Delivery Time
3-4 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Main Export Market(s)
Western Europe, Australia, Middle East, Central America, South America, Asia, Eastern Europe, North America, Africa

Main Domestic Market
All India

About Buserelin For Peak Identification

Buserelin for peak identification Synonym: Buserelin acetate salt, des-Gly10-[D-Ser[t-Bu]6]-LH-RH ethylamide acetate salt, pGlu-His-Trp-Ser-Tyr-D-Ser(t-Bu)-Leu-Arg-Pro-NHEt acetate salt Empirical Formula (Hill Notation): C60H86N16O13 C2H4O2Molecular Weight: 1299.48CAS Number: 68630-75-1

FAQs of Buserelin For Peak Identification:

Q: What is the primary application of Buserelin For Peak Identification?

A: Buserelin For Peak Identification is primarily used in industrial applications.

Q: What medical conditions is Buserelin For Peak Identification approved to treat?

A: Buserelin is approved for the treatment of hormone-responsive cancers like prostate cancer and premenopausal breast cancer, sex hormone-dependent uterine diseases including endometrial hyperplasia, endometriosis, and uterine fibroids, as well as in assisted reproduction for female infertility.